SSGJ-709-101
SSGJ-709-101: A Phase I Study to Evaluate the Safety, Pharmacokinetics and Anti-tumor Activity of SSGJ-709 in Patients with Advanced Malignant Tumors
Trial summary:
Receptor status / problem studied:
Inclusion criteria
Exclusion criteria
Open for recruitment
Trial Title
SSGJ-709-101
Diagnosis
Advanced solid tumours
Type of trial
Pharmaceutical
Type of treatement
Medical Oncology
Phase
I
Locations
Investigators
Principal Investigator